Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP James Taylor joins INC Research

He was previously VP global clinical trial management at the US pharma firm

INC Research, James TaylorINC Research has appointed Pfizer's former head of clinical trials James Taylor as its new VP, clinical development.

Taylor, who was VP, global clinical trial management at Pfizer, joins the clinical research organisation (CRO) immediately, and will act as the primary liaison between INC Research and its biopharma customers.

It is the second major personnel change during 2013 for INC Research following the appointment of former chief operating officer Jamie Macdonald to CEO in January.

Macdonald commented on the decision to hire Taylor: "Jim is an accomplished leader with global experience across all phases of complex enterprise operations involving the execution of clinical trials."

He added: "Having worked in large pharma for many years, he brings a strong customer perspective, which allows him to anticipate our customers' needs and communicate their requirements more effectively.”

Taylor spent almost a decade at Pfizer, initially serving as VP, worldwide head contracts and outsourcing before assuming his role in clinical trial management.

Prior to joining Pfizer, Taylor served at Sanofi as senior director outsourcing management and he has also held positions at Baxter Healthcare and Omnicare Clincial Research.

12th March 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics